Biohaven Ltd. (BHVN) Q3 2021 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Biohaven Ltd..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.109 -- 00:00:04.071 Quarter 2021 earnings call. 00:00:04.113 -- 00:00:07.296 Speaking on today's call from Biohaven are Dr. 00:00:07.296 -- 00:00:13.081 Vlad Chorich, our Chief Executive Officer, Jim Englehart, Chief Financial Officer, 00:00:13.081 -- 00:00:16.564 BJ Jones, Chief Commercial Officer, and Dr. 00:00:16.564 -- 00:00:21.869 Elise Stock, Chief Medical Officer. We also welcome Nick Ligonowitz, 00:00:21.869 -- 00:00:25.307 Global President, Pfizer Internal Medicine. 00:00:25.307 -- 00:00:30.970 Earlier this morning, we issued a press release announcing the third quarter 2021 highlights. 00:00:30.970 -- 00:00:36.052 A copy of this press release can be found on our website at biowaveandpharma.com, 00:00:36.133 -- 00:00:40.294 and we will file our Form 10-Q later today. 00:00:40.416 -- 00:00:44.978 Before we begin, let me remind everyone that today's discussion contains forward-looking 00:00:44.978 -- 00:00:50.416 statements based on the environment as we currently see it, and includes risks and uncertainties. 00:00:50.416 -- 00:00:55.540 A list and description of risks and uncertainties associated with an investment in Biohaven 00:00:55.540 -- 00:00:57.862 can be found in the company's filings with the U.S. 00:00:57.862 -- 00:01:02.966 Securities and Exchange Commission. Please be aware that you should not place undue 00:01:02.966 -- 00:01:06.709 reliance on any forward-looking statements we make today. 00:01:06.709 -- 00:01:10.292 For this call, we will focus on non-GAAP financial measures. 00:01:10.292 -- 00:01:15.397 Detailed descriptions of these non-GAAP measures and reconciliations to the most comparable 00:01:15.397 -- 00:01:19.318 GAAP measures can be found in our SEC filings. 00:01:19.318 -- 00:01:24.362 An archive of today's call will...